Abrams CS, Shattil SJImmunological detection of activated platelets in clinical disorders . Thromb Haemost1991;65:467.
2.
Sims PJ, Faione EM, Wiedmer T., Shattil SLComplement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem1988;263: 18205.
3.
Nomura S., Yanabu M., Kido H., et al. Antiplatelet autoantibodyrelated microparticles in patients with idiopathic (autoimmune) thrombo-cytopenic purpura. Ann Hematol1991;62:103.
4.
Nomura S., Yanabu M., Miyake T., et al. Relationship of microparticles with β2- glycoprotein I and P-selectin positivity to anticardiolipin antibodies in immune thrombocytopenic purpura. Ann Hematol1995;70:25.
5.
Nomura S., Yanabu M., Kido H., et al. Significance of cytokines and CD68-positive microparticles in immune thrombocytopenic purpura. Eur J Haematol1995;55:49.
6.
Nomura S., Komiyama Y., Miyake T., et al. Amyloid-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemost1994;72:519.
7.
Nomura S., Suzuki M., Katsura K., et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis1995;116:235.
8.
Abrams CS, Ellison N., Budzynski AZ, Shattil SJDirect detection of activated platelets and platelet-derived microparticles in humans. Blood1990;75:128.
9.
Katsura K., Nomura S., Xie GL, et al. Platelet procoagulant activity during peripheral blood stem cell harvest. Clin Appl Thrombosis/ Hemostasis1997;3:124.
10.
Miyazaki Y. , Nomura S., Miyake T., et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles . Blood1996;88:3456.
